FDA Approves Aminolevulinic Acid Hydrochloride as an Optical Imaging Agent Indicated in Gliomas

June 20, 2017 – On June 6, the U.S. Food and Drug Administration (FDA) approved aminolevulinic acid hydrochloride, known as ALA HCl, as an optical imaging agent indicated in patients with gliomas (suspected World Health Organization [WHO] Grades III or IV) for preoperative imaging, as an adjunct for the visualization of malignant tissue during surgery. The efficacy of 20 mg/kg ALA was evaluated in three clinical trials involving patients 18 to 75 … (leggi tutto)